India to Australia: Furosemide Export Trade Route

The India to Australia Furosemide corridor is one of India's established pharmaceutical export routes, with 59 shipments documented worth a combined $1.2M USD. The route is dominated by IPCA LABORATORIES LIMITED, which alone accounts for roughly 55% of all export value, reflecting the consolidated nature of India's furosemide manufacturing sector.

Across 8 active suppliers, the average shipment value stands at $20.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (65%) and air (15%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during July–September, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 19.8%, placing it at rank #12 among India's top furosemide export destinations globally.

On the import side, key buyers of Indian furosemide in Australia include NA, TO THE ORDER, BAXTER HEALTHCARE PTY. LIMITED and 10 others. NA is the single largest importer with 20 shipments valued at $635.6K USD.

India's furosemide exports to Australia are driven primarily by a handful of large-scale manufacturers. IPCA LABORATORIES LIMITED with 21 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — IPCA LABORATORIES LIMITED, BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED, IPCA LABORATORIES LIMITED — together account for 87% of total trade value on this route. The average shipment value of $20.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as apo - frusemide 40mg tablets (furosemide40mg tablets)(117858x1x100's pack=11785800 tablets)nos and pharmaceutical:uremide 20mg tablets (furosemide tablets 20mg )(1x50s) (10800000tbs) (harmless medicines), suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, NA is the largest importer with 20 shipments worth $635.6K USD — representing 52% of all furosemide imports from India on this route. A total of 13 buyers are active on this corridor.